Sens. Press OMB For Delayed Medical Device Rule

Law360, Washington (February 10, 2012, 5:36 PM ET) -- Three senators urged the White House Office of Management and Budget on Thursday to release a rule from the U.S. Food and Drug Administration on post-market medical device tracking that has been under review for over seven months.

In a letter directed to OMB Acting Director Jeffrey Zients, U.S. Sens. Herb Kohl, D-Wis.; Chuck Grassley, R-Iowa; and Richard Blumenthal, D-Conn., emphasized that the regulation could help the FDA bridge gaps in its medical device safety surveillance.

The FDA forwarded the so-called unique-device-identifier proposal to the OMB...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers